EA201101397A1 - Inhibitors of Human Immunodeficiency Virus Replication - Google Patents

Inhibitors of Human Immunodeficiency Virus Replication

Info

Publication number
EA201101397A1
EA201101397A1 EA201101397A EA201101397A EA201101397A1 EA 201101397 A1 EA201101397 A1 EA 201101397A1 EA 201101397 A EA201101397 A EA 201101397A EA 201101397 A EA201101397 A EA 201101397A EA 201101397 A1 EA201101397 A1 EA 201101397A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitors
immunodeficiency virus
human immunodeficiency
virus replication
useful
Prior art date
Application number
EA201101397A
Other languages
Russian (ru)
Inventor
Клаудио Стурино
Патрик Дерой
Мартин Даплессис
Пол Дж. Эдуардз
Анне-Мари Фоше
Тедди Халмос
Клинт Джеймс
Жан-Эрик Лакосте
Эрик Мейленфант
Джоанни Минвилл
Луис Моренси
Себастьен Морен
Мартин Тремблей
Кристиане Йоаким
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA201101397A1 publication Critical patent/EA201101397A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

В заявке описаны соединения формулы (I)в которой R, R, A, А, А, А, Х и Y являются такими, как определено в настоящем изобретении, применимые в качестве ингибиторов репликации ВИЧ (вирус иммунодефицита человека).The application describes compounds of formula (I) in which R, R, A, A, A, A, X, and Y are as defined herein, useful as inhibitors of HIV replication (human immunodeficiency virus).

EA201101397A 2009-04-09 2010-04-07 Inhibitors of Human Immunodeficiency Virus Replication EA201101397A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16803209P 2009-04-09 2009-04-09
US26368909P 2009-11-23 2009-11-23
PCT/CA2010/000478 WO2010115264A1 (en) 2009-04-09 2010-04-07 Inhibitors of hiv replication

Publications (1)

Publication Number Publication Date
EA201101397A1 true EA201101397A1 (en) 2012-05-30

Family

ID=42934876

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201101397A EA201101397A1 (en) 2009-04-09 2010-04-07 Inhibitors of Human Immunodeficiency Virus Replication

Country Status (15)

Country Link
US (1) US8349839B2 (en)
EP (1) EP2417140B1 (en)
JP (1) JP5643290B2 (en)
KR (1) KR20120034592A (en)
CN (1) CN102388051A (en)
AR (1) AR076252A1 (en)
AU (1) AU2010234241A1 (en)
BR (1) BRPI1014821A2 (en)
CA (1) CA2758149A1 (en)
CL (1) CL2011002258A1 (en)
EA (1) EA201101397A1 (en)
IL (1) IL214606A0 (en)
MX (1) MX2011010582A (en)
TW (1) TW201103940A (en)
WO (1) WO2010115264A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013091096A1 (en) 2011-12-20 2013-06-27 Boehringer Ingelheim International Gmbh Condensed triclyclic compounds as inhibitors of hiv replication
JP6820854B2 (en) * 2015-01-18 2021-01-27 エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ MAP4K4 (HGK) inhibitor
AU2016215432B2 (en) 2015-02-02 2020-07-30 Valo Early Discovery, Inc. 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
TW201636329A (en) 2015-02-02 2016-10-16 佛瑪治療公司 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
IL275490B1 (en) 2017-12-22 2024-01-01 Ravenna Pharmaceuticals Inc Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
WO2020028482A1 (en) * 2018-07-31 2020-02-06 The Trustees Of The University Of Pennsylvania Small molecules that sensitize hiv-1 infected cells to antibody dependent cellular cytotoxicity
CN111560022A (en) * 2020-05-13 2020-08-21 深圳职业技术学院 Tetrahydrobenzofuran [3,2-d ] pyrimidine derivative and preparation method and application thereof
CN116332947A (en) * 2021-12-24 2023-06-27 上海海和药物研究开发股份有限公司 Pyrimidine-2 (1H) -keto bicyclic compounds with MAT2A inhibitory activity and application thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8016A (en) * 1851-04-01 Improvement in the manufacture of india-rubber
JPH06172365A (en) * 1992-12-11 1994-06-21 Yamasa Shoyu Co Ltd 10-thiaisoalloxazine derivative and its use
JPH06220059A (en) * 1993-01-28 1994-08-09 Tanabe Seiyaku Co Ltd Condensed pyrimidine derivative and its production
US6593337B1 (en) * 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
EP1209158A1 (en) 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substituted beta-carbolines
TWI270547B (en) * 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US7008958B2 (en) 2002-05-21 2006-03-07 Bristol-Myers Squibb Company 2-substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising same
US20030139427A1 (en) 2002-08-23 2003-07-24 Osi Pharmaceuticals Inc. Bicyclic pyrimidinyl derivatives and methods of use thereof
US7884221B2 (en) 2002-11-08 2011-02-08 Kaneka Corporation Method of separating ergosterol
JP2006508145A (en) 2002-11-15 2006-03-09 テイボテク・フアーマシユーチカルズ・リミテツド Substituted indole pyridinium as an anti-infective compound
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
WO2004096807A2 (en) * 2003-04-28 2004-11-11 Tibotec Pharmaceuticals Ltd. Hiv integrase inhibitors
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
US7435735B2 (en) * 2003-10-20 2008-10-14 Merck & Co., Inc. Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
WO2005076861A2 (en) * 2004-02-04 2005-08-25 University Of Virginia Patent Foundation Compounds that inhibit hiv particle formation
CN1976930B (en) 2004-05-17 2011-01-19 泰博特克药品有限公司 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
AP2006003791A0 (en) 2004-05-17 2006-10-31 Tibotec Pharm Ltd 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
AR052304A1 (en) * 2004-05-17 2007-03-14 Tibotec Pharm Ltd COMPOUNDS 1,5- DIHIDRO - PIRIDO (3,2-B) INDOL-2-ONAS4- REPLACED, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS
AR049102A1 (en) 2004-05-17 2006-06-28 Tibotec Pharm Ltd PHENYL DERIVATIVES - 1, 5 - DIHIDRO - PIRIDO [3,2 -B] INDOL - 2 - WAVES 5- SUBSTITUTED AND DERIVATIVES OF PHENYL - 2 - OXO - 1,2 - DIHYDRO - BENZO [4, 5] FURO [3 , 2 -B] PIRIDIN - 3 - CARBONITRILE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND ITS USE AS A MEDICINAL PRODUCT WITH INHIBITORY ACTIVITY OF HIV VIRUS.
WO2005110411A1 (en) * 2004-05-17 2005-11-24 Tibotec Pharmaceuticals Ltd. Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other hiv inhibitors
ES2341559T3 (en) * 2004-07-23 2010-06-22 The Medicines Company (Leipzig) Gmbh PIRIDO (3 ', 2': 4,5) HAVING (3,2-D) PYRIMIDINES AND PIRIDO (3 ', 2': 4,5) FURO (3,2-D) PIRIMIDINES REPLACED FOR USE AS INHIBITORS OF THE RELEASE OF PDA-4 AND / OR TNF-ALFA.
DE602005025900D1 (en) 2004-09-30 2011-02-24 Boehringer Ingelheim Pharma ALKYNIL-BASED DERIVATIVES OF BENZOPHENONES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
CA2583622A1 (en) 2004-10-13 2006-04-27 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AR066386A1 (en) 2004-12-17 2009-08-19 Glenmark Pharmaceuticals Sa CONDENSED HETEROCICLICAL COMPOUNDS, METHODS AND INTERMEDIARIES FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THEIR USE IN THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF PDE-4
WO2006074192A2 (en) 2005-01-03 2006-07-13 Bionaut Pharmaceuticals, Inc. Treatment of inflammatory disorders
WO2007025090A2 (en) 2005-08-25 2007-03-01 Kalypsys, Inc. Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
JP2009525310A (en) * 2006-02-03 2009-07-09 テイボテク・フアーマシユーチカルズ・リミテツド Methods for treating mutated HIV
WO2008037783A1 (en) 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
DE102006062203A1 (en) * 2006-12-22 2008-06-26 Curacyte Discovery Gmbh Substituted 5H-pyrimido [5,4-b] indoles as inducers of apoptosis in B-CLL cells
WO2008101867A1 (en) 2007-02-19 2008-08-28 Smithkline Beecham Corporation Purine derivatives as immunomodulators
WO2008119070A1 (en) 2007-03-28 2008-10-02 Trustees Of Boston University Methods of treatment using sirt modulators and compositions containing sirt1 modulators
WO2009085185A1 (en) 2007-12-19 2009-07-09 Amgen Inc. Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

Also Published As

Publication number Publication date
KR20120034592A (en) 2012-04-12
CN102388051A (en) 2012-03-21
US8349839B2 (en) 2013-01-08
BRPI1014821A2 (en) 2016-04-05
EP2417140A4 (en) 2013-02-20
TW201103940A (en) 2011-02-01
EP2417140A1 (en) 2012-02-15
WO2010115264A1 (en) 2010-10-14
MX2011010582A (en) 2011-10-19
JP2012523380A (en) 2012-10-04
EP2417140B1 (en) 2014-11-26
AU2010234241A1 (en) 2011-09-08
US20100261714A1 (en) 2010-10-14
CA2758149A1 (en) 2010-10-14
JP5643290B2 (en) 2014-12-17
IL214606A0 (en) 2011-09-27
AR076252A1 (en) 2011-05-26
CL2011002258A1 (en) 2012-02-10

Similar Documents

Publication Publication Date Title
EA201101620A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
EA201000777A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
EA201101397A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
CY1124043T1 (en) HUMAN IMMUNODEFICIENCY VIRUS-NEUTRALIZING ANTIBODIES AND METHODS OF USING THEM
EA201290880A1 (en) NEW CONNECTIONS - ENZYME INHIBITORS
EA201590384A1 (en) 6-AMINO ACID-HETEROARYDYHYDROPYRIMIDINES FOR THE TREATMENT AND PREVENTION OF INFECTION OF THE HEPATITIS B VIRUS
EA201590358A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
EA201000950A1 (en) AZOLYLMETHYLOXYRANES, THEIR APPLICATION, AND ALSO CONTAINING THEM
CL2014000612A1 (en) Compounds derived from macrocyclic prolines, inhibitors of hepatitis C virus serine proteases (vhc); pharmaceutical composition that includes them; and its use to treat a viral infection such as hepatitis C virus (vhc) infection.
DK2220076T3 (en) Inhibitors of the replication of human immunodeficiency virus
EA201490596A1 (en) NEW DYHYDROCHINOLIN-2-IT DERIVATIVES
DK2019825T3 (en) Inhibitors of human immunodeficiency virus replication
EA201391127A1 (en) C-17 AND C-3 MODIFIED TRITERPENOIDS WITH INHIBITOR ACTIVITY OF HIV MATURATION
CL2012002489A1 (en) Compounds derived from silyl naphtho-imidazole; pharmaceutical composition; and its use to prevent or treat a hepatitis c virus infection.
CL2011002830A1 (en) Compounds derived from haloalkyl heteroaryl benzamides; pharmaceutical composition use of the composition in the treatment of a viral infection, such as hepatitis b and c virus.
EA201490588A1 (en) METHODS OF TREATMENT OF HEPATITIS C VIRUS
ECSP11011310A (en) CARBA ANALOGS - NUCLEOSIDE FOR ANTIVIRAL TREATMENT
CL2012000573A1 (en) Compounds derived from biphenyl-pyrrolidinyl-imidazole; pharmaceutical composition comprising them; its use in the treatment of an hcv viral infection.
EA201290053A1 (en) FLAVIVIRIDAE VIRUS INHIBITORS
EA201690687A1 (en) REPLICATION INHIBITORS OF THE VIRUS OF IMMUNODEFICIENCY
EA200901490A1 (en) CHEMICAL COMPOUNDS
EA201101194A1 (en) APPLICATION OF ROSUVASTATIN LACTOL AS A MEDICINE PREPARATION
EA201490643A1 (en) NEW BETULINIC ACID DERIVATIVES WITH ANTI-VIRUS ACTIVITY
EA201590688A1 (en) DERIVATIVES N-PROP-2-INILKARBOXAMIDA AND THEIR APPLICATION AS TRPA1 ANTAGONISTS
WO2008118849A3 (en) Hiv-1 protease inhibitors